...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: If we follow AMRN's pattern...

It's the Adcom that's killing them. Means there is still significant uncertainty about Vascepa, at least enough that the FDA wants a public discussion.

Share
New Message
Please login to post a reply